Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Comprehensive review on oral disintegrating films.

Nagaraju T, Gowthami R, Rajashekar M, Sandeep S, Mallesham M, Sathish D, Kumar YS.

Curr Drug Deliv. 2013 Feb;10(1):96-108. Review.

PMID:
22920576
2.

An introduction to fast dissolving oral thin film drug delivery systems: a review.

Kathpalia H, Gupte A.

Curr Drug Deliv. 2013 Dec;10(6):667-84. Review.

PMID:
24274635
3.

Fast dissolving films: a review.

Chaturvedi A, Srivastava P, Yadav S, Bansal M, Garg G, Sharma PK.

Curr Drug Deliv. 2011 Jul;8(4):373-80. Review.

PMID:
21453260
4.

Orally disintegrating systems: innovations in formulation and technology.

Goel H, Rai P, Rana V, Tiwary AK.

Recent Pat Drug Deliv Formul. 2008;2(3):258-74. Review.

PMID:
19075912
5.

A review on mouth dissolving films.

Dahiya M, Saha S, Shahiwala AF.

Curr Drug Deliv. 2009 Oct;6(5):469-76. Review.

PMID:
19751197
6.

Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.

Lou H, Liu M, Qu W, Hu Z, Brunson E, Johnson J, Almoazen H.

Drug Dev Ind Pharm. 2014 Jul;40(7):910-8. doi: 10.3109/03639045.2013.789907. Epub 2013 Apr 26.

PMID:
23621768
7.

Fast disintegrating tablets: Opportunity in drug delivery system.

Parkash V, Maan S, Deepika, Yadav SK, Hemlata, Jogpal V.

J Adv Pharm Technol Res. 2011 Oct;2(4):223-35. doi: 10.4103/2231-4040.90877.

8.

The technologies used for developing orally disintegrating tablets: a review.

Badgujar BP, Mundada AS.

Acta Pharm. 2011 Jun;61(2):117-39. doi: 10.2478/v10007-011-0020-8. Review.

PMID:
21684842
9.

[Orally disintegrating tablets--advantages and drawbacks].

Tho I.

Tidsskr Nor Laegeforen. 2012 Feb 21;132(4):424-5. doi: 10.4045/tidsskr.10.1464. Norwegian.

10.

Confectionery-based dose forms.

Tangso KJ, Ho QP, Boyd BJ.

Curr Drug Deliv. 2015;12(1):56-62. Review.

PMID:
25146440
11.

Dissolution testing of orally disintegrating tablets.

Kraemer J, Gajendran J, Guillot A, Schichtel J, Tuereli A.

J Pharm Pharmacol. 2012 Jul;64(7):911-8. doi: 10.1111/j.2042-7158.2012.01473.x. Epub 2012 Apr 8. Review.

PMID:
22686339
12.

New Generation of Orally Disintegrating Tablets for Sustained Drug Release: A Propitious Outlook.

Elwerfalli AM, Ghanchi Z, Rashid F, Alany RG, ElShaer A.

Curr Drug Deliv. 2015;12(6):652-67. Review.

PMID:
25760951
13.

Drug-delivery products and the Zydis fast-dissolving dosage form.

Seager H.

J Pharm Pharmacol. 1998 Apr;50(4):375-82. Review.

PMID:
9625481
14.

Oral strip technology: overview and future potential.

Dixit RP, Puthli SP.

J Control Release. 2009 Oct 15;139(2):94-107. doi: 10.1016/j.jconrel.2009.06.014. Epub 2009 Jun 24. Review.

PMID:
19559740
15.

Advances in orodispersible films for drug delivery.

Hoffmann EM, Breitenbach A, Breitkreutz J.

Expert Opin Drug Deliv. 2011 Mar;8(3):299-316. doi: 10.1517/17425247.2011.553217. Epub 2011 Feb 2. Review.

PMID:
21284577
16.

Compressed orally disintegrating tablets: excipients evolution and formulation strategies.

Al-khattawi A, Mohammed AR.

Expert Opin Drug Deliv. 2013 May;10(5):651-63. doi: 10.1517/17425247.2013.769955. Epub 2013 Feb 7. Review.

PMID:
23387409
17.

Effect of polymer, plasticizer and filler on orally disintegrating film.

Liew KB, Tan YT, Peh KK.

Drug Dev Ind Pharm. 2014 Jan;40(1):110-9. doi: 10.3109/03639045.2012.749889. Epub 2013 Jan 11.

PMID:
23311593
18.

Recent patents and trends in orally disintegrating tablets.

AlHusban FA, El-Shaer AM, Jones RJ, Mohammed AR.

Recent Pat Drug Deliv Formul. 2010 Nov;4(3):178-97. Review.

PMID:
20626334
19.

[Research progress on the oral solid rapidly disintegrating dosage form].

Shen L, Lin X, Xu DS, Feng Y.

Zhongguo Zhong Yao Za Zhi. 2005 Jan;30(2):89-92. Review. Chinese.

PMID:
15714807
20.

Disintegration of chemotherapy tablets for oral administration in patients with swallowing difficulties.

Siden R, Wolf M.

J Oncol Pharm Pract. 2013 Jun;19(2):145-50. doi: 10.1177/1078155212455446. Epub 2012 Aug 20.

PMID:
22907947

Supplemental Content

Support Center